New England Journal of Medicine

Vol. 392, Issue 12 Issue 12 2025
22
Articles

Articles in this Issue

Asundexian versus Apixaban in Patients with Atrial Fibrillation

Mar 27, 2025 pp. 1246-1248 10.1056/nejmc2501201

Health Care Bridges — Pathways toward Trust in Gaza and Beyond

Yasmeen Abu Fraiha, Abdalrahman Ahmed, Noam Alon et al. Mar 27, 2025 pp. 1145-1148 10.1056/nejmp2416553

Beyond Glucocorticoids for IgG4-Related Disease

Robert Spiera Mar 27, 2025 pp. 1232-1233 10.1056/nejme2413286

Inebilizumab for Treatment of IgG4-Related Disease

John H. Stone, Arezou Khosroshahi, Wen Zhang et al. Mar 27, 2025 pp. 1168-1177 10.1056/nejmoa2409712

Unexplained or Refractory Chronic Cough in Adults

Richard S. Irwin, J. Mark Madison Mar 27, 2025 pp. 1203-1214 10.1056/nejmra2309906

The Definition of Failure

Jason Gurney Mar 27, 2025 pp. 1151-1153 10.1056/nejmp2414167

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

Komal L. Jhaveri, Patrick Neven, Monica Lis Casalnuovo et al. Mar 27, 2025 pp. 1189-1202 10.1056/nejmoa2410858

Case 9-2025: A 59-Year-Old Man with Hepatocellular Carcinoma

Kathleen E. Corey, David M. Dudzinski, Alexander R. Guimaraes et al. Mar 27, 2025 pp. 1216-1227 10.1056/nejmcpc1909622

Partnerships between Pharmaceutical and Telehealth Companies — Increasing Access or Driving Inappropriate Prescribing?

Erin C. Fuse Brown, Olivier J. Wouters, Ateev Mehrotra Mar 27, 2025 pp. 1148-1151 10.1056/nejmp2500379

Nivolumab plus Ipilimumab in Advanced Melanoma

Mar 27, 2025 pp. 1245-1246 10.1056/nejmc2501311

Transcatheter Valve Replacement in Severe Tricuspid Regurgitation

Mar 27, 2025 pp. 1243-1245 10.1056/nejmc2501560

Severe HDL Cholesterol Reduction with Bempedoic Acid and Fenofibrate

Francesco Sbrana, Federico Bigazzi, Beatrice Dal Pino Mar 27, 2025 pp. 1241-1242 10.1056/nejmc2413726

Sézary Syndrome

Heloise Mazoyer, Claude Bachmeyer Mar 27, 2025 10.1056/nejmicm2411990

Beta-Blocker Therapy after Acute Myocardial Infarction — To Block or Not to Block?

Christos P. Kotanidis, David J. Maron, Tomas Jernberg Mar 27, 2025 pp. 1234-1236 10.1056/nejmclde2410735

BPROAD — End of the Road for Debate on Systolic Blood-Pressure Goals in Type 2 Diabetes?

Shuchi Anand, Srinivasan Beddhu Mar 27, 2025 pp. 1230-1232 10.1056/nejme2501656

Order out of Chaos

Eric J. Rubin Mar 27, 2025 pp. 1229-1230 10.1056/nejme2502874

Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps

Brian J. Lipworth, Joseph K. Han, Martin Desrosiers et al. Mar 27, 2025 pp. 1178-1188 10.1056/nejmoa2414482

Vaccinating against <i>Clostridioides difficile</i> Infection

Vincent B. Young Mar 27, 2025 pp. 1237-1240 10.1056/nejmcibr2413794

NEJM at AHA — Intensive Blood-Pressure Control in Patients with Type 2 Diabetes

Eric J. Rubin, Jane Leopold, Stephen Morrissey Mar 27, 2025 10.1056/nejme2414476

Meconium Ileus

Annie Le-Nguyen, Michael-Andrew Assaad Mar 27, 2025 pp. 1215-1215 10.1056/nejmicm2409795

Red Urine after Administration of Hydroxocobalamin

Nilesh Anand Devanand, Robin de Meirsman Mar 27, 2025 10.1056/nejmicm2413940

NEJM Outbreaks Update — H5N1

Eric J. Rubin, Lindsey R. Baden, Yoshihiro Kawaoka et al. Mar 27, 2025 10.1056/nejme2502267

All Issues

Journal Info

Publisher Massachusetts Medical Society
ISSN 0028-4793
E-ISSN 0096-6762
Subject Social Sciences
Language English
View Full Journal Page